Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.
about
Locally Produced IL-10 Limits Cutaneous Vaccinia Virus SpreadAdverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusPredominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicityGM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.Genome-wide genetic associations with IFNγ response to smallpox vaccineFailure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.Mast cell-induced lung injury in mice infected with H5N1 influenza virus.Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infectionGenomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia VirusCD4 and CD8 T cells participate in the immune memory response against Vaccinia virus after a previous natural infection.Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trialModulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.
P2860
Q27315106-B64EF1DC-2F74-4259-BD7A-46ADB96C7922Q27346800-EB0CE243-2F9C-48B0-B8FE-9F38FD9823C7Q30418993-345A7774-A235-4BCA-A458-3707D308BC36Q33828605-E7938070-E4D1-44C6-BF63-A90DE4A14AD4Q34023265-EF9770CF-D9AE-4FD0-8DC8-94E374C04BBEQ34221936-6A5F793A-C5CB-4FE9-A6A0-EE1DB7EE3D0DQ35805278-18C6C455-FD1C-481F-92C3-14A40E844D56Q35826260-C19FA1EA-36E5-41D6-8995-F222343AEAC4Q36013764-A18CDDB3-4A92-49EF-B32A-B5317B7BADB4Q36281104-9B1725FB-012D-475E-8774-14D544683C99Q37536272-B4DA3935-E532-4468-9B23-B65C06BEB79DQ42376121-4D356808-F55B-4469-B6A1-8B25F92340BFQ50533334-8457856A-501B-467C-A26B-CFC407F14C1FQ55714396-7BE97750-78D8-4FC5-90C8-4B3582D3BB96
P2860
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@ast
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@en
type
label
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@ast
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@en
prefLabel
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@ast
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@en
P2093
P2860
P356
P1476
Control of vaccinia virus skin ...... ry CD4+ lymphocytes in humans.
@en
P2093
Behazine Combadière
Bénédicte Puissant-Lubrano
Daniel Garin
Frederick Gay
Jean-Marc Crance
Olivia Bonduelle
Philippe Bossi
P2860
P304
P356
10.1172/JCI38506
P407
P577
2010-04-01T00:00:00Z